Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Micron Technology Surges 19 Reaches 1 Trillion Market Cap for First Time General Motors Unveils AllElectric Cadillac Vistiq With 300Mile Range Expanding Luxury EV Lineup Hybrid Village Stores An Innovative Retail Model Addressing Rural Germanys SocioEconomic Challenges Major Indexes Hit Record Highs as Oil Prices Slide on USIran Peace Deal Prospects MercedesBenz Signals Potential Shift Toward Defence Sector Amid Automotive Pressures White Mountains Insurance Group WTM Q2 2025 Earnings EPS Misses Estimates but Stock Edges Higher QVCGP Q3 2025 Earnings Preferred Stock Reports EPS of 989 Amid Continued Losses Gold Fields Q4 2016 Earnings Narrow EPS Miss Sends Shares Down 135 AA Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges SHLS Q1 2026 Earnings Earnings Beat Driven by Margin Strength Shares Rise 377 American Rebel Holdings AREB Surges 26 as Penny Stock Finds New Buying Interest at 006 Titan Machinery Inc TITN Gains 166 Approaches Key Resistance Level Royal Gold RGLD Edges Lower Near Support as Metals Sector Consolidates GAVA ETF Slips 049 as Grayscale Avalanche Staking Fund Consolidates Between Support and Resistance US Consumer Sentiment Remains Depressed Amid Inflation Geopolitical Tensions and Trade Policy Uncertainty Huawei Unveils New Chip Design Approach Amid US Restrictions Intensifying Rivalry with Nvidia and Apple Mercury Valuation Surges to 52 Billion Highlighting Fintech Resilience Oil Prices Jump 2 on Escalating US Military Strikes Against Iran Brent Breaches 96 ALIT Q1 2026 Earnings EPS Surprises 34 Above Estimates Stock Edges Higher SHW Q1 2026 Earnings EPS Surpasses Estimates on Solid Execution ANGX Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty COCP Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline EIG Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline